What patents cover Obizur, and who holds them?
Obizur is the brand name for recombinant porcine factor VIII (rpFVIII), marketed for hemophilia A patients with inhibitors. Patent coverage for Obizur typically sits in two layers: (1) composition-of-matter and biologic process patents for the rpFVIII product, and (2) method-of-use and formulation/production-related patents that can extend enforceability beyond the earliest filing date. Specific patent numbers and assignees depend on the country/region (for example, U.S. vs. Europe) and the manufacturing site/process claims tied to the biologic.
How long do Obizur patents last (U.S. and EU)?
Patent life is driven by filing date, patent term rules, and whether patent term adjustments or supplementary protections apply. Biologics can also have market exclusivity protections that function alongside patents. Exact “expiration” dates are therefore not universal for Obizur and must be determined per jurisdiction and per specific patent family.
How can Obizur face generic or biosimilar competition?
Obizur’s market protection generally comes from a combination of patents and regulatory exclusivity. Biosimilar pathways and entry timing usually depend on when key patents (and any exclusivity periods) expire or are no longer enforceable. If a biosimilar’s development challenges particular claims, litigation can determine whether entry is blocked or delayed even after some protections lapse.
Are there challenges or licensing around Obizur patents?
For established biologics like Obizur, patent disputes commonly target the scope and validity of specific claims (for example, process claims, formulation details, or method claims). When patent holders sue to block biosimilar entry, courts can grant injunctions or narrow what the biosimilar must avoid. The practical outcome is often that biosimilar launch timing hinges on which patents are found valid/enforceable and which are designed around.
What to check to find the exact Obizur patent list and expiration dates
To get a precise, searchable “Obizur patents” answer (with numbers and dates), you typically need to search patent registries by:
- the product name (Obizur) and active ingredient (recombinant porcine factor VIII),
- assignee/company names tied to the product,
- related patent family members, and
- jurisdiction-specific databases (U.S. Patent and Trademark Office records, and EU member-state or EPO-linked coverage).
If you tell me which country (U.S., EU/UK, Canada, etc.) you care about, I can narrow what to look for and explain how to interpret the expiration timelines for that jurisdiction.
Sources
No sources were provided in the prompt, so I can’t cite specific Obizur patent documents or assignees.